Goldman Sachs upgrades this software provider ahead of Sept. investor day

Goldman Sachs upgraded Clearwater Analytics (CWAN) to Buy from Neutral, maintaining a $27 price target, driven by the belief that execution risk from recent acquisitions is now fully priced in and the core business continues to exhibit robust free cash flow growth exceeding 20% annually. Despite a 33% year-to-date decline in 2025, the bank anticipates a positive catalyst path, including an early September investor conference, and projects 20% core business growth over the next 3-5 years, prompting a nearly 6% premarket surge in CWAN shares.

Analysis

Goldman Sachs has upgraded Clearwater Analytics (CWAN) to Buy from Neutral, signaling a potential inflection point for the stock after a 33% decline year-to-date in 2025. The core of the bank's thesis is that market concerns regarding the integration of acquired assets, such as Enfusion, are now fully priced into the shares. The analysis presents a compelling valuation argument, suggesting that when stripping out acquisitions, Clearwater's core business trades at an approximate 31x free cash flow multiple, a level deemed attractive for a business consistently growing FCF at over 20% annually. Goldman projects this growth to be sustainable over the next three to five years, driven by the competitive strength of Clearwater's cloud-native solution against legacy products. A key near-term catalyst is the company's upcoming Analyst Day on September 3rd, which could provide management with a platform to address integration concerns and reinforce the core growth narrative. This bullish stance from Goldman, which maintained its $27 price target, is notably more conservative than the broader Wall Street consensus price target of over $31, which implies 70% upside and is supported by a unanimous Buy rating from all covering analysts according to FactSet.

Key Decisions for Investors

• Investors could view the significant year-to-date underperformance as a strategic entry point, as the rationale for the upgrade hinges on the belief that acquisition-related execution risk is now fully priced in.
• The upcoming Analyst Day on September 3rd should be considered a critical catalyst; any positive updates on acquisition integration or a reaffirmation of the core growth outlook could drive the stock higher.
• Monitor future earnings reports for continued free cash flow growth above 20% to validate the core thesis underpinning the stock's re-rating.
• Given that all covering analysts rate the stock a buy and the consensus price target implies 70% upside, the Goldman Sachs upgrade adds significant weight to the existing bullish sentiment, suggesting a potential floor for the stock.